Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.130
+0.080 (7.62%)
At close: Sep 19, 2024, 4:00 PM
1.090
-0.040 (-3.54%)
Pre-market: Sep 20, 2024, 4:32 AM EDT
Coherus BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 159.24 | 102.89 | 63.55 | 417.2 | 541.16 | 177.67 | Upgrade
|
Short-Term Investments | - | 14.86 | 128.13 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 159.24 | 117.75 | 191.68 | 417.2 | 541.16 | 177.67 | Upgrade
|
Cash Growth | 10.04% | -38.57% | -54.05% | -22.91% | 204.59% | 145.55% | Upgrade
|
Accounts Receivable | 175.25 | 260.52 | 109.96 | 123.02 | 157.05 | 141.99 | Upgrade
|
Receivables | 313.57 | 260.52 | 109.96 | 123.02 | 157.05 | 141.99 | Upgrade
|
Inventory | 62.16 | 62.61 | 38.79 | 37.64 | 44.23 | 9.81 | Upgrade
|
Prepaid Expenses | 22.96 | 34.76 | 40.8 | 24.46 | 25.04 | 13.54 | Upgrade
|
Total Current Assets | 557.93 | 475.63 | 381.23 | 602.32 | 767.48 | 343.01 | Upgrade
|
Property, Plant & Equipment | 3.33 | 11.03 | 14.44 | 16.01 | 10.11 | 16.49 | Upgrade
|
Goodwill | - | 0.94 | 0.94 | 0.9 | 0.94 | 0.94 | Upgrade
|
Other Intangible Assets | 55.46 | 70.73 | 4.99 | 2.66 | 2.62 | 2.62 | Upgrade
|
Other Long-Term Assets | 58.14 | 71.27 | 79.24 | 57.44 | 60.5 | 45.87 | Upgrade
|
Total Assets | 674.86 | 629.6 | 480.85 | 679.33 | 841.65 | 408.93 | Upgrade
|
Accounts Payable | 76.82 | 35.22 | 11.53 | 16.16 | 15.2 | 25.99 | Upgrade
|
Accrued Expenses | 239.33 | 291.11 | 122.85 | 145.68 | 127.32 | 86.79 | Upgrade
|
Current Portion of Leases | 1.44 | 2.15 | 4.32 | 3.49 | 3.13 | 2.2 | Upgrade
|
Other Current Liabilities | 145.42 | 3.3 | - | - | - | - | Upgrade
|
Total Current Liabilities | 463.01 | 331.77 | 138.69 | 165.33 | 145.65 | 114.97 | Upgrade
|
Long-Term Debt | 264.1 | 473.37 | 471.06 | 408.28 | 404.02 | 178.39 | Upgrade
|
Long-Term Leases | 4.17 | 5.33 | 5.05 | 7.25 | 9.95 | 10.26 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.1 | 1.1 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 26.6 | 11.46 | 3.47 | 0.75 | 1.05 | 0.1 | Upgrade
|
Total Liabilities | 758.96 | 823.03 | 618.27 | 581.61 | 560.68 | 303.71 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 1,406 | 1,386 | 1,204 | 1,148 | 1,044 | 1,001 | Upgrade
|
Retained Earnings | -1,490 | -1,580 | -1,342 | -1,050 | -762.75 | -895 | Upgrade
|
Comprensive Income & Other | -0.27 | -0.25 | -0.25 | -0.27 | -0.27 | -0.56 | Upgrade
|
Total Common Equity | -84.11 | -193.43 | -137.42 | 97.73 | 280.97 | 105.21 | Upgrade
|
Shareholders' Equity | -84.11 | -193.43 | -137.42 | 97.73 | 280.97 | 105.21 | Upgrade
|
Total Liabilities & Equity | 674.86 | 629.6 | 480.85 | 679.33 | 841.65 | 408.93 | Upgrade
|
Total Debt | 269.7 | 480.84 | 480.42 | 419.02 | 417.1 | 190.84 | Upgrade
|
Net Cash (Debt) | -110.46 | -363.09 | -288.74 | -1.83 | 124.06 | -13.17 | Upgrade
|
Net Cash Per Share | -1.01 | -3.86 | -3.72 | -0.02 | 1.49 | -0.18 | Upgrade
|
Filing Date Shares Outstanding | 115.21 | 112.71 | 79.61 | 77.28 | 72.79 | 70.62 | Upgrade
|
Total Common Shares Outstanding | 115.2 | 112.22 | 78.85 | 76.93 | 72.51 | 70.37 | Upgrade
|
Working Capital | 94.93 | 143.86 | 242.54 | 437 | 621.83 | 228.04 | Upgrade
|
Book Value Per Share | -0.73 | -1.72 | -1.74 | 1.27 | 3.87 | 1.50 | Upgrade
|
Tangible Book Value | -139.56 | -265.1 | -143.35 | 94.16 | 277.41 | 101.65 | Upgrade
|
Tangible Book Value Per Share | -1.21 | -2.36 | -1.82 | 1.22 | 3.83 | 1.44 | Upgrade
|
Machinery | 17.76 | 17.73 | 17.39 | 16.04 | 18.57 | 16.25 | Upgrade
|
Construction In Progress | - | - | 0.7 | 0.39 | 0.31 | 1.5 | Upgrade
|
Leasehold Improvements | 5.75 | 5.75 | 6.2 | 5.94 | 5.83 | 4.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.